Skip to content
AnalystLens

BALL Annual Report, Year Ended Dec 31, 2014

Filing Date
Filed February 20, 2015
Period End
December 31, 2014
Security
BALL
One revenue dollarkept$0.05
In the record · 2016–202610-K1110-Q338-K136

BALL filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 136 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’17Nov ’17
  2. FY2019 annual report10-K · Feb ’20Feb ’20
  3. Restructuring8-K · Aug ’22Aug ’22
  4. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 10-K filed February 20, 2015. Cited figures are marked; the original filing is the authoritative source.

Ball Corporation reported 2014 net sales of $8.57 billiona and net earnings attributable to Ball Corporation of $470.0 million, or $3.30 diluted earnings per share, compared with $406.8 million ($2.73 per diluted share) in 2013.

Ball's packaging businesses accounted for 89 percent of 2014 net sales, with metal beverage packaging, Americas and Asia, the largest segment at 50 percent of consolidated net sales. Aerospace and technologies contributed 11 percent. Comparable earnings were $552.8 millionb ($3.88 per diluted share), and free cash flow was $621.7 million, up from $460.7 million in 2013.

Operating cash flow was $1,012.5 millionc, and total interest-bearing debt declined to $3.2 billion from $3.6 billion. The dominant event in the filing is the proposed acquisition of Rexam PLC, announced February 19, 2015. Ball would pay 407 pence in cash and 0.04568 new Ball shares for each Rexam share, valuing Rexam's equity at £4.3 billion ($6.6 billion).

To fund the cash portion, Ball entered into a £3.3 billion unsecured bridge loan agreement, and it also entered into a new $3 billiond revolving credit facility and announced redemption of $1 billion of senior notes due 2020 and 2021, with a pre-tax charge of approximately $56.3 million. The risk factors emphasize closing conditions, including shareholder, UK court, and antitrust approvals, the possibility of significant divestitures, and break payments of 1 to 7 percent of total consideration if the deal fails.

For investors, the key tradeoffs are improved 2014 operating results and cash generation against a substantially larger, more leveraged company if the Rexam acquisition closes. The filing also notes 2015 expectations of operating cash flow around $1 billion, capital expenditures of approximately $400 million, and free cash flow of around $600 million.

Key Highlights

  1. 2014 net sales of $8.57 billion, up from $8.47 billion in 2013; net earnings attributable to Ball of $470.0 million, or $3.30 diluted EPS, versus $2.73 in 2013.
  2. Comparable earnings rose to $552.8 million ($3.88 per diluted share) from $489.6 million ($3.28 per diluted share) in 2013.
  3. Free cash flow was $621.7 million in 2014, up from $460.7 million, on operating cash flow of $1,012.5 million.
  4. Proposed acquisition of Rexam PLC valued at £4.3 billion ($6.6 billion), with 407 pence cash plus 0.04568 new Ball shares per Rexam share.
  5. Ball entered into a £3.3 billion unsecured bridge loan and a new $3 billion revolving credit facility to fund the transaction and refinance existing facilities.
  6. Total interest-bearing debt fell to $3.2 billion at December 31, 2014, from $3.6 billion a year earlier; the company is redeeming $1 billion of 2020 and 2021 senior notes at a pre-tax charge of about $56.3 million.
  7. Aerospace and technologies backlog declined to $765 million from $938 million, reflecting completion of several multi-year contracts including satellite launches.

Follow one dollar

Of each $1.00 of revenue in FY2014, Ball kept $0.05.

  1. Revenue$8.57B100.0%
  2. Cost of revenue−$7.14B83.3%
  3. Gross profit$1.43B16.7%
  4. Operating costs−$594.7M6.9%
  5. Operating income$839.0M9.8%
  6. Interest, other & tax−$369.0M4.3%
  7. Net income$470.0M5.5%
Computed from 10-KFY2014filed February 20, 2015Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2014 revenue went

$8.57B
  • Cost of revenue: $7.14B, 83% of revenue
  • Net income: $470.0M, 5.5% of revenue
  • R&D: $27.0M, 0.3% of revenue
  • SG&A: $466.0M, 5.4% of revenue
  • Other operating costs: $101.7M, 1.2% of revenue
  • Interest, other & tax: $369.0M, 4.3% of revenue

Kept 5.5% as net incomeNet income $470.0M · 5.5%R&D $27.0M · 0.3%Other operating costs $101.7M · 1.2%

Full revenue history →

Financial Statements

FY2014 against FY2013

Line itemFY2014FY2013Change
Revenue$8.57B$8.47B+1.2%
Gross Profit$1.43B$1.34B+7.1%
R&D Expenses$27.00M$31.20M−13.5%
SG&A Expenses$466.00M$418.60M+11.3%
Operating Expenses$7.73B$7.67B+0.8%
Operating Income$839.00M$795.40M+5.5%
Interest Expense$160.00M$211.80M−24.5%
Net Income$470.00M$406.80M+15.5%
EPS (Basic)$1.70$1.40+21.5%
EPS (Diluted)$1.65$1.36+20.9%
Shares Outstanding (Basic)277.02M291.89M−5.1%
Shares Outstanding (Diluted)284.86M298.45M−4.6%

Frequently Asked Questions

  1. What is the Rexam acquisition and how will it be paid for?

    Ball announced a recommended offer for all outstanding Rexam PLC shares, with each Rexam share receiving 407 pence in cash and 0.04568 new Ball shares. The transaction values Rexam at 610 pence per share, an equity value of £4.3 billion ($6.6 billion). The cash portion is to be financed by a £3.3 billion unsecured bridge loan, and part of the funding is through issuance of Ball common stock.

  2. What could prevent the Rexam deal from closing?

    Closing depends on Ball shareholder approval of the share issuance, a UK court-sanctioned scheme of arrangement with Rexam shareholder approvals, expiration of antitrust waiting periods including under the Hart-Scott-Rodino Act and in the European Union and Brazil, and the absence of a material adverse effect on Rexam. The filing notes that regulators may require significant divestitures, which Ball would be obligated to accept under the co-operation agreement.

  3. What break payment could Ball owe if the acquisition fails?

    If the acquisition is not consummated by August 19, 2016 due to unobtained regulatory approvals, or if Ball changes its recommendation citing regulatory approvals, Ball would pay Rexam a break payment of 7 percent of the total consideration. Lower percentages of 3 percent or 1 percent apply in certain shareholder-vote scenarios within six months of the offer announcement.

  4. How did Ball's 2014 profitability and cash flow compare with 2013?

    Net sales increased to $8,570.0 million from $8,468.1 million. Net earnings attributable to Ball Corporation rose to $470.0 million from $406.8 million. Cash provided by operating activities increased to $1,012.5 million from $839.0 million, and free cash flow increased to $621.7 million from $460.7 million. The filing attributes the sales increase primarily to higher metal beverage container sales volumes and higher aerospace program revenues.

  5. What are Ball's expectations for 2015 cash flow and capital spending?

    Based on information currently available, Ball estimates cash flows from operating activities for 2015 in the range of $1 billion, capital expenditures of approximately $400 million, and free cash flow in the range of $600 million. The company intends to use operating cash flow to fund stock repurchases, dividends, growth capital projects, and acquisitions that meet its criteria.